Provider
QP100-18 Pharmacy Benefit Exclusion for Crinone (progesterone) Gel, Finacea (alzelaic acid) Foam, Glatopa (glatiramer acetate) Injection
Program effective Date: Nov 28, 2018
Documents & Forms Results
Displaying 2671 - 2680 of 3100 results
Provider
2018 December Provider Press
Program effective Date: Nov 28, 2018
Provider
QP92-18 Addition of Drug to the Topical Lidocaine Prior Authorization with Quantity Limit Program
Program effective Date: Nov 14, 2018
Provider
QP96-18 Clarification Regarding the use of PLUTO for Minnesota Health Care Program Subscribers Effective December 1, 2018
Program effective Date: Nov 14, 2018
Provider
QP90-18 Addition of Drugs to the Self-Administered Oncology Agents Prior Authorization with Quantity Limit Program
Program effective Date: Nov 14, 2018
Provider
QP93-18 Technical Issues with Authorization and Referral Tool on Availity Resolved
Program effective Date: Nov 14, 2018
Provider
QP89-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization with Quantity Limit Criteria: Circadian Rhythm Disorder
Program effective Date: Nov 14, 2018
Provider
QP91-18 Addition of Drug to the Thrombopoietin Receptor Agonists Prior Authorization with Quantity Limit Program
Program effective Date: Nov 14, 2018
Provider
QP88-18 Pharmacy Benefit Update - New Drug-Related Prior Authorization Criteria: Phenylketonuria
Program effective Date: Nov 14, 2018
Provider
QP86-18 Addition of Drug to the Calcitonin Gene-Related Peptide (CGRP) Prior Authorization with Quantity Limit Program
Program effective Date: Nov 14, 2018